Intriguingly, we observed that EZH2 was strongly overexpressed in high-grade DCIS adjacent to triple-negative breast carcinoma, whereas UDH in benign lesions did not overexpress EZH2. The gene discussed is EZH2; the disease is triple-negative breast carcinoma.